Cargando…
Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling
BACKGROUND: Chemoresistance often causes the failure of treatment and death of patients with advanced non-small-cell lung cancer. However, there is still no resistance genes signature and available enriched signaling derived from a comprehensive RNA-Seq data analysis of lung cancer patients that cou...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102725/ https://www.ncbi.nlm.nih.gov/pubmed/35551652 http://dx.doi.org/10.1186/s13287-022-02859-3 |
_version_ | 1784707396126375936 |
---|---|
author | Zhang, Yujia Qiu, Fengjun Ye, Tingjie Lee, Sau Har Xu, Jiatuo Jia, Lingyan Zeng, Rui Wang, Xiaoling Hu, Xudong Yan, Xiaofeng Li, Hua Lu, Yanlin Wang, Xiaoling Jiang, Rilei Xu, Wei |
author_facet | Zhang, Yujia Qiu, Fengjun Ye, Tingjie Lee, Sau Har Xu, Jiatuo Jia, Lingyan Zeng, Rui Wang, Xiaoling Hu, Xudong Yan, Xiaofeng Li, Hua Lu, Yanlin Wang, Xiaoling Jiang, Rilei Xu, Wei |
author_sort | Zhang, Yujia |
collection | PubMed |
description | BACKGROUND: Chemoresistance often causes the failure of treatment and death of patients with advanced non-small-cell lung cancer. However, there is still no resistance genes signature and available enriched signaling derived from a comprehensive RNA-Seq data analysis of lung cancer patients that could act as a therapeutic target to re-sensitize the acquired resistant cancer cells to chemo-drugs. Hence, in this study, we aimed to identify the resistance signature for clinical lung cancer patients and explore the regulatory mechanism. METHOD: Analysis of RNA-Seq data from clinical lung cancer patients was conducted in R studio to identify the resistance signature. The resistance signature was validated by survival time of lung cancer patients and qPCR in chemo-resistant cells. Cytokine application, small-interfering RNA and pharmacological inhibition approaches were applied to characterize the function and molecular mechanism of EREG and downstream signaling in chemoresistance regulation via stemness. RESULTS: The RTK and vitamin D signaling were enriched among resistance genes, where 6 genes were validated as resistance signature and associated with poor survival in patients. EREG/ERK signaling was activated by chemo-drugs in NSCLC cells. EREG protein promoted the NSCLC resistance to chemo-drugs by increasing stemness genes expression. Additionally, inhibition of EREG/ErbB had downregulated ERK signaling, resulting in decreased expression of stemness-associated genes and subsequently re-sensitized the resistant NSCLC cells and spheres to chemo-drugs. CONCLUSIONS: These findings revealed 6 resistance genes signature and proved that EREG/ErbB regulated the stemness to maintain chemoresistance of NSCLC via ERK signaling. Therefore, targeting EREG/ErbB might significantly and effectively resolve the chemoresistance issue. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02859-3. |
format | Online Article Text |
id | pubmed-9102725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-91027252022-05-14 Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling Zhang, Yujia Qiu, Fengjun Ye, Tingjie Lee, Sau Har Xu, Jiatuo Jia, Lingyan Zeng, Rui Wang, Xiaoling Hu, Xudong Yan, Xiaofeng Li, Hua Lu, Yanlin Wang, Xiaoling Jiang, Rilei Xu, Wei Stem Cell Res Ther Research BACKGROUND: Chemoresistance often causes the failure of treatment and death of patients with advanced non-small-cell lung cancer. However, there is still no resistance genes signature and available enriched signaling derived from a comprehensive RNA-Seq data analysis of lung cancer patients that could act as a therapeutic target to re-sensitize the acquired resistant cancer cells to chemo-drugs. Hence, in this study, we aimed to identify the resistance signature for clinical lung cancer patients and explore the regulatory mechanism. METHOD: Analysis of RNA-Seq data from clinical lung cancer patients was conducted in R studio to identify the resistance signature. The resistance signature was validated by survival time of lung cancer patients and qPCR in chemo-resistant cells. Cytokine application, small-interfering RNA and pharmacological inhibition approaches were applied to characterize the function and molecular mechanism of EREG and downstream signaling in chemoresistance regulation via stemness. RESULTS: The RTK and vitamin D signaling were enriched among resistance genes, where 6 genes were validated as resistance signature and associated with poor survival in patients. EREG/ERK signaling was activated by chemo-drugs in NSCLC cells. EREG protein promoted the NSCLC resistance to chemo-drugs by increasing stemness genes expression. Additionally, inhibition of EREG/ErbB had downregulated ERK signaling, resulting in decreased expression of stemness-associated genes and subsequently re-sensitized the resistant NSCLC cells and spheres to chemo-drugs. CONCLUSIONS: These findings revealed 6 resistance genes signature and proved that EREG/ErbB regulated the stemness to maintain chemoresistance of NSCLC via ERK signaling. Therefore, targeting EREG/ErbB might significantly and effectively resolve the chemoresistance issue. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02859-3. BioMed Central 2022-05-12 /pmc/articles/PMC9102725/ /pubmed/35551652 http://dx.doi.org/10.1186/s13287-022-02859-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhang, Yujia Qiu, Fengjun Ye, Tingjie Lee, Sau Har Xu, Jiatuo Jia, Lingyan Zeng, Rui Wang, Xiaoling Hu, Xudong Yan, Xiaofeng Li, Hua Lu, Yanlin Wang, Xiaoling Jiang, Rilei Xu, Wei Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling |
title | Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling |
title_full | Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling |
title_fullStr | Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling |
title_full_unstemmed | Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling |
title_short | Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling |
title_sort | epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via erk signaling |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102725/ https://www.ncbi.nlm.nih.gov/pubmed/35551652 http://dx.doi.org/10.1186/s13287-022-02859-3 |
work_keys_str_mv | AT zhangyujia epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT qiufengjun epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT yetingjie epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT leesauhar epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT xujiatuo epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT jialingyan epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT zengrui epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT wangxiaoling epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT huxudong epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT yanxiaofeng epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT lihua epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT luyanlin epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT wangxiaoling epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT jiangrilei epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling AT xuwei epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling |